A Study of a New PET Scanner in People With Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMemorial Sloan Kettering Cancer Center
About this trial
The researchers are doing this study to test the capabilities of a new total-body PET scanner called the Biograph Vision Quadra. The researchers want to learn whether this scanner can produce better PET/CT images and provide more useful imaging information than standard PET/CT scanners.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with histologically-confirmed non-small cell lung carcinoma (NSCLC) with a single or multiple lung nodules.
Patients who are undergoing a planned PET-CT scan at main campus of MSK.
Patients must be ≥ 18 years old
Patients with disease within the chest, abdomen or pelvis, who could benefit from visualizing the pharmacokinetics of radiotracer uptake within all disease sites simultaneously.
Disqualifiers
Patients who suffer from claustrophobia.
Women who are pregnant or breast-feeding.
Patients < 18 years of age
Trial population
Any MSKCC patients with histologically confirmed cancer, who will be scheduled to receive a planned PET-CT scan at the MSK main campus may be enrolled in this image evaluation and improvement study. Potential patients will be identified by a member of the patient's treatment team at MSKCC, who will introduce the study to them.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Biograph Vision Quadra scanner
Diagnostic testnew total-body PET scanner, 1 or 2 additional scans with the Biograph Vision Quadra scanner.
PET/CT
Diagnostic testScheduled PET/CT scan
Treatment groups
90 Participants
are divided into 1 treatment groupGroup A: Patients with lung, head and neck, and prostate cancer2 interventions
Trial outcomes
Primary outcomes
1
image quality
Detection of any new/additional lesions on the delayed scan will be recorded using standard clinical interpretation.
Time frame
3 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov